Page last updated: 2024-11-04
sb 202190 and Sunburn
sb 202190 has been researched along with Sunburn in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Sunburn: An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hildesheim, J | 1 |
| Awwad, RT | 1 |
| Fornace, AJ | 1 |
Other Studies
1 other study available for sb 202190 and Sunburn
| Article | Year |
|---|---|
p38 Mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses.
Topics: Acute Disease; Animals; Apoptosis; Dermatitis; Enzyme Inhibitors; Epidermis; Imidazoles; Male; MAP K | 2004 |